Stefanie Fischer
Sankt Gallen, SG 9007, Switzerland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 40 publications
Safety and preliminary efficacy results of a new micellar formulation of docetaxel in patients with metastatic castration-resistant prostate cancer - SAKK 67/20 trial.
Journal: Cancer chemotherapy and pharmacology
Published: April 08, 2026
European Association of Urology Guidelines on Testicular Cancer: Summary of the 2026 Guidelines.
Journal: European urology
Published: March 09, 2026
Comparison of Relapse Risk Prediction Models During Active Surveillance in Stage I Seminoma: A Retrospective Multicenter Cohort Study.
Journal: International journal of cancer
Published: January 13, 2026
Interdisciplinary Swiss Consensus Recommendations on Management of Advanced Prostate Cancer.
Journal: Praxis
Published: May 28, 2025
A Bayesian Network Meta-analysis of Systemic Treatments for Metastatic Castration-Resistant Prostate Cancer in First- and Subsequent Lines.
Journal: Targeted oncology
Published: April 20, 2025
Case Report: Abiraterone in brain metastases from prostate cancer.
Journal: Frontiers in oncology
Published: January 05, 2025
First Single-Centre Experience with the Novel HIF-α Inhibitor Belzutifan in Switzerland.
Journal: Current oncology (Toronto, Ont.)
Published: December 22, 2024
Redefining Good-prognosis Seminoma: Implications for Clinical Practice of the Updated International Germ Cell Cancer Collaborative Group Classification and Results from the SEMITrends Survey.
Journal: European urology oncology
Published: November 04, 2024
BRCA2 germline mutation carrier with five malignancies: a case report.
Journal: Hereditary cancer in clinical practice
Published: August 29, 2024
First Indicator of Relapse in Testicular Cancer and Implications for Follow-up: Analysis of the Swiss Austrian German Testicular Cancer Cohort Study (SAG TCCS).
Journal: European urology open science
Published: August 14, 2024
Last Updated: 09/26/2026